αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.

Saved in:
Bibliographic Details
Title: αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
Authors: de Groot JS; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Ratze MA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van Amersfoort M; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Eisemann T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Vlug EJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Niklaas MT; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Jonkers J; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Rooij J; Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands., Derksen PW; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Source: The Journal of pathology [J Pathol] 2018 Aug; Vol. 245 (4), pp. 456-467. Date of Electronic Publication: 2018 Jun 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29774524
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Groot+JS%22">de Groot JS</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ratze+MA%22">Ratze MA</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Amersfoort+M%22">van Amersfoort M</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Eisemann+T%22">Eisemann T</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vlug+EJ%22">Vlug EJ</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Niklaas+MT%22">Niklaas MT</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chin+SF%22">Chin SF</searchLink>; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Caldas+C%22">Caldas C</searchLink>; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22van+Diest+PJ%22">van Diest PJ</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jonkers+J%22">Jonkers J</searchLink>; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Rooij+J%22">de Rooij J</searchLink>; Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Derksen+PW%22">Derksen PW</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220204634%22">The Journal of pathology</searchLink> [J Pathol] 2018 Aug; Vol. 245 (4), pp. 456-467. <i>Date of Electronic Publication: </i>2018 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+And+Sons%22">John Wiley And Sons </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0204634 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9896 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223417%22">00223417 </searchLink><i>NLM ISO Abbreviation: </i>J Pathol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29774524
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/path.5099
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 456
    Titles:
      – TitleFull: αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Groot JS
      – PersonEntity:
          Name:
            NameFull: Ratze MA
      – PersonEntity:
          Name:
            NameFull: van Amersfoort M
      – PersonEntity:
          Name:
            NameFull: Eisemann T
      – PersonEntity:
          Name:
            NameFull: Vlug EJ
      – PersonEntity:
          Name:
            NameFull: Niklaas MT
      – PersonEntity:
          Name:
            NameFull: Chin SF
      – PersonEntity:
          Name:
            NameFull: Caldas C
      – PersonEntity:
          Name:
            NameFull: van Diest PJ
      – PersonEntity:
          Name:
            NameFull: Jonkers J
      – PersonEntity:
          Name:
            NameFull: de Rooij J
      – PersonEntity:
          Name:
            NameFull: Derksen PW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2018 Aug
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9896
          Numbering:
            – Type: volume
              Value: 245
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The Journal of pathology
              Type: main
ResultId 1